heronsign9
About
Successive afatinib along with osimertinib throughout people with EGFR mutation-positive NSCLC and purchased T790M: An international non-interventional study (UpSwinG).
Successive afatinib along with osimertinib throughout people with EGFR mutation-positive NSCLC and purchased T790M: An international non-interventional study (UpSwinG).